A prospective study of reticular macular disease
- PMID: 21550118
- PMCID: PMC3150615
- DOI: 10.1016/j.ophtha.2011.01.029
A prospective study of reticular macular disease
Abstract
Purpose: To determine the risk of progression to advanced age-related macular degeneration (AMD) conferred by reticular pseudodrusen (RPD), an imaging presentation of reticular macular disease (RMD), in high-risk fellow eyes of subjects with AMD and unilateral choroidal neovascularization (CNV) in a large, prospective study.
Design: Cohort study.
Participants: Two hundred seventy-one subjects with AMD; 94 with RPD and 177 without RPD.
Methods: Images from a cohort of 271 subjects with AMD in the Nutritional AMD treatment phase II (NAT 2) Study, a 3-year prospective study of subjects with unilateral CNV and large soft drusen in the fellow eye, were studied. The fellow eye, at high risk for advanced AMD developing, was the study eye. There were 5 visits per subject. Imaging at each visit consisted of color, red-free, and blue-light photography and fluorescein angiography. The images were analyzed for the presence of RPD, following disease progression throughout the 3-year study.
Main outcome measures: The development of advanced AMD (CNV or geographic atrophy).
Results: For the 271 subjects who completed the full 3-year study, there was a significantly higher rate of advanced AMD (56% or 53/94) in fellow eyes with RPD at any visit compared with eyes without RPD (32% or 56/177; P < 0.0001, chi-square test; relative risk [RR], 1.8; 95% confidence interval [CI], 1.4-2.4). The chance of developing advanced AMD in the fellow eye in women with RPD (66%) was more than double that of women without RPD (30%; P < 0.00001; RR, 2.2; 95% CI, 1.6-3.1).
Conclusions: To the authors' knowledge, this is the first comprehensive prospective study of RMD, a distinct clinical phenotype of AMD that includes RPD. It provides strong confirmation that RMD, a disease entity with stereotypical presentations across imaging methods, is associated with a high risk of progression to advanced AMD, perhaps on an inflammatory or vascular basis. Reticular macular disease deserves wider recognition and consideration by clinicians caring for patients with AMD.
Financial disclosure(s): Proprietary or commercial disclosure may be found after the references.
Copyright © 2011 American Academy of Ophthalmology. Published by Elsevier Inc. All rights reserved.
Conflict of interest statement
Conflict of Interest: No authors have any conflicting interest to disclose.
Figures
Similar articles
-
Reticular pseudodrusen: a risk factor for geographic atrophy in fellow eyes of individuals with unilateral choroidal neovascularization.Ophthalmology. 2014 Jun;121(6):1252-6. doi: 10.1016/j.ophtha.2013.12.034. Epub 2014 Feb 8. Ophthalmology. 2014. PMID: 24518615 Free PMC article.
-
Autofluorescence characteristics of early, atrophic, and high-risk fellow eyes in age-related macular degeneration.Invest Ophthalmol Vis Sci. 2006 Dec;47(12):5495-504. doi: 10.1167/iovs.05-1318. Invest Ophthalmol Vis Sci. 2006. PMID: 17122141 Free PMC article.
-
Clinical characteristics of reticular pseudodrusen in the fellow eye of patients with unilateral neovascular age-related macular degeneration.Ophthalmology. 2014 Sep;121(9):1748-55. doi: 10.1016/j.ophtha.2014.03.015. Epub 2014 May 21. Ophthalmology. 2014. PMID: 24856310
-
Perspectives on reticular pseudodrusen in age-related macular degeneration.Surv Ophthalmol. 2016 Sep-Oct;61(5):521-37. doi: 10.1016/j.survophthal.2016.02.005. Epub 2016 Mar 17. Surv Ophthalmol. 2016. PMID: 26994868 Review.
-
Reticular pseudodrusen in age-related macular degeneration.Optom Vis Sci. 2014 Aug;91(8):854-9. doi: 10.1097/OPX.0000000000000287. Optom Vis Sci. 2014. PMID: 24950032 Review.
Cited by
-
Internal Carotid Artery Stenosis and Ipsilateral Subretinal Drusenoid Deposits.Invest Ophthalmol Vis Sci. 2024 Feb 1;65(2):37. doi: 10.1167/iovs.65.2.37. Invest Ophthalmol Vis Sci. 2024. PMID: 38407857 Free PMC article.
-
Subretinal Drusenoid Deposits in a Patient With HELLP (Hemolysis, Elevated Liver Enzymes, Low Platelet) Syndrome.Cureus. 2024 Jan 14;16(1):e52239. doi: 10.7759/cureus.52239. eCollection 2024 Jan. Cureus. 2024. PMID: 38352084 Free PMC article.
-
Two potentially distinct pathways to geographic atrophy in age-related macular degeneration characterized by quantitative fundus autofluorescence.Eye (Lond). 2023 Aug;37(11):2281-2288. doi: 10.1038/s41433-022-02332-8. Epub 2023 Jan 9. Eye (Lond). 2023. PMID: 36617586 Free PMC article.
-
Longitudinal change of reticular pseudodrusen area in ultrawide-field imaging.Sci Rep. 2022 Dec 26;12(1):22383. doi: 10.1038/s41598-022-25947-z. Sci Rep. 2022. PMID: 36572671 Free PMC article.
-
A Deep Learning Framework for the Detection and Quantification of Reticular Pseudodrusen and Drusen on Optical Coherence Tomography.Transl Vis Sci Technol. 2022 Dec 1;11(12):3. doi: 10.1167/tvst.11.12.3. Transl Vis Sci Technol. 2022. PMID: 36458946 Free PMC article.
References
-
- Klein R, Davis MD, Magli YL, et al. The Wisconsin Age-Related Maculopathy Grading System. Ophthalmology. 1991;98:1128–1134. - PubMed
-
- Mimoun G, Soubrane G, Coscas G. Macular drusen [in French] J Fr Ophtalmol. 1990;13:511–530. - PubMed
-
- Arnold JJ, Sarks SH, Killingsworth MC, Sarks JP. Reticular pseudodrusen: a risk factor in age-related maculopathy. Retina. 1995;15:183–191. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
